BioXcel Expands Into CNS Orphan Disease Therapeutics
BRANFORD, Conn., Feb. 08, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced its expansion into CNS Orphan Diseases that require novel …